Arch Therapeutics, Inc. declared the first shipments of AC5 advanced wound system under its new reimbursement program. AC5 was a synthetic self-assembling wound care product that allowed clinicians with multimodal support in all stages of the wound healing process.
Convatec Group PLC entered into an agreement to acquire Triad Life Sciences Inc which develops biologically derived innovative products to meet the requirements in surgical and chronic wounds and burns.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?